152 related articles for article (PubMed ID: 22759332)
21. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
22. Carcinogenesis of Helicobacter pylori.
Correa P; Houghton J
Gastroenterology; 2007 Aug; 133(2):659-72. PubMed ID: 17681184
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
Slomiany BL; Slomiany A
J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
[TBL] [Abstract][Full Text] [Related]
24. In vitro inhibition of Helicobacter pylori growth and adherence to gastric mucosal cells by Pycnogenol.
Rohdewald P; Beil W
Phytother Res; 2008 May; 22(5):685-8. PubMed ID: 18350522
[TBL] [Abstract][Full Text] [Related]
25. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.
Yang JC; Shun CT; Chien CT; Wang TH
J Nutr; 2008 Nov; 138(11):2084-90. PubMed ID: 18936202
[TBL] [Abstract][Full Text] [Related]
26. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
27. A novel in vitro infection model of Helicobacter pylori using mucin-producing murine gastric surface mucous cells.
Takahashi T; Matsumoto T; Nakamura M; Matsui H; Kiyohara H; Sasakawa C; Yamada H
Helicobacter; 2004 Aug; 9(4):302-12. PubMed ID: 15270744
[TBL] [Abstract][Full Text] [Related]
28. Anti-adhesive effect of an acidic polysaccharide from Aloe vera L. var. chinensis (Haw.) Berger on the binding of Helicobacter pylori to the MKN-45 cell line.
Xu C; Ruan XM; Li HS; Guo BX; Ren XD; Shuang JL; Zhang Z
J Pharm Pharmacol; 2010 Dec; 62(12):1753-9. PubMed ID: 21054402
[TBL] [Abstract][Full Text] [Related]
29. Antiadhesive property of microalgal polysaccharide extract on the binding of Helicobacter pylori to gastric mucin.
Loke MF; Lui SY; Ng BL; Gong M; Ho B
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):231-8. PubMed ID: 17521357
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice.
Burger O; Weiss E; Sharon N; Tabak M; Neeman I; Ofek I
Crit Rev Food Sci Nutr; 2002; 42(3 Suppl):279-84. PubMed ID: 12058986
[TBL] [Abstract][Full Text] [Related]
31. Imunosuppression by a corticosteroid fails to exacerbate Helicobacter pylori infection in a mouse model of gastric colonization.
Conlan JW; KuoLee R; Webb A; Perry MB
Can J Microbiol; 1999 Nov; 45(11):975-80. PubMed ID: 10588046
[TBL] [Abstract][Full Text] [Related]
32. Morphological aspects of the cytotoxic action of Helicobacter pylori.
Taniguchi Y; Ido K; Kimura K; Satoh K; Yoshida Y; Takimoto T; Kihira K; Ookawara S; Mato M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S17-21. PubMed ID: 7537615
[TBL] [Abstract][Full Text] [Related]
33. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
35. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
36. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach.
Wittschier N; Faller G; Hensel A
Phytomedicine; 2007 Apr; 14(4):285-8. PubMed ID: 17350240
[TBL] [Abstract][Full Text] [Related]
37. Experimental Helicobacter pylori infection induces antral-predominant, chronic active gastritis in hispid cotton rats (Sigmodon hispidus).
Mähler M; Heidtmann W; Niewiesk S; Gruber A; Fossmark R; Beil W; Hedrich H; Wagner S
Helicobacter; 2005 Aug; 10(4):332-44. PubMed ID: 16104950
[TBL] [Abstract][Full Text] [Related]
38. Prevention by bovine milk against Helicobacter pylori-associated atrophic gastritis through its adherence inhibition.
Akedo I; Tatsuta M; Narahara H; Iishi H; Uedo N; Yano H; Ishihara R; Higashino K; Ishida T; Takemura K; Matsumoto S
Hepatogastroenterology; 2004; 51(55):277-81. PubMed ID: 15011885
[TBL] [Abstract][Full Text] [Related]
39. Distribution of Helicobacter pylori in a Mongolian gerbil gastric ulcer model.
Miyata H; Yagi K; Kimura M; Kijima H; Isobe Y; Kaneda Y; Akashi T
Lab Anim Sci; 1999 Dec; 49(6):622-7. PubMed ID: 10638497
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis.
Thao TD; Ryu HC; Yoo SH; Rhee DK
Biochem Pharmacol; 2008 Jun; 75(11):2135-46. PubMed ID: 18436193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
